Yasumitsu Akahoshi

Chronic Administration of Oral Vasopressin Type 2 Receptor Antagonist Tolvaptan Exerts Both Myocardial and Renal Protective Effects in Rats With Hypertensive Heart Failure

Hanako Morooka, Yoshitaka Iwanaga, Yodo Tamaki et al. · Circulation Heart Failure · 2012 · 52 citations · Full text

Medicine, Cardiology, Pharmacology +17

Ecklonia cava polyphenol protects the liver against ethanol-induced injury in rats

Mai Takahashi, Naoko Satake, Haruka Yamashita et al. · Biochimica et Biophysica Acta (BBA) - General Subjects · 2012 · 29 citations

Veterinary Medicine, Pharmacology, Toxicology +14

1′-Acetoxychavicol Acetate Inhibits Adipogenesis in 3T3-L1 Adipocytes and in High Fat-Fed Rats

Rie Ohnishi, Isao Matsui‐Yuasa, Yohei Deguchi et al. · The American Journal of Chinese Medicine · 2012 · 27 citations

Life Sciences, Nutritional Sciences, Pharmacology +17

Is Hyperuricemia a Risk Factor for Arteriosclerosis? Uric Acid and Arteriosclerosis in Apolipoprotein E-Deficient Mice

Hirokazu Wakuda, Shinya Uchida, Masahiko Ikeda et al. · Biological and Pharmaceutical Bulletin · 2014 · 16 citations · Full text

Veterinary Medicine, Biochemistry, Nutrition +9

Effects of Long-term Blockade of Vasopressin Receptor Types 1a and 2 on Cardiac and Renal Damage in a Rat Model of Hypertensive Heart Failure

Tomoyuki Ikeda, Yoshitaka Iwanaga, Heitaro Watanabe et al. · Journal of Cardiovascular Pharmacology · 2015 · 11 citations

Medicine, Cardiology, Pharmacology +17